A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 05 May 2014
At a glance
- Drugs Tovetumab (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors MedImmune
- 05 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Mar 2013 Planned End Date changed from 1 Jan 2014 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 18 Jul 2012 Additional trial location (Bulgaria) added as reported by ClinicalTrials.gov.